SCHEDULE: Altium Capital Discloses 0.22% Stake in Femto Tech
Beneficial Ownership Disclosure
Altium Capital Management LLC and its affiliates have disclosed a 0.22% beneficial ownership stake in Femto Technologies Inc. common stock, primarily through Series A Warrants.
Summary
- Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC jointly filed a Schedule 13G.
- The reporting persons collectively beneficially own 6,576 shares of Femto Technologies Inc. common stock.
- This represents 0.22% of the outstanding common stock, based on 2,926,526 shares as of December 31, 2024, as reported in the Issuer's Amendment No. 1 to Form 20-F filed on May 2, 2025.
- The ownership is primarily derived from Series A Warrants purchased by the Fund.
- A 'Warrant Blocker' limits the exercise of these Series A Warrants, preventing beneficial ownership from exceeding 4.99% of outstanding common stock. The reported 6,576 shares do not account for this blocker, meaning the actual beneficially owned shares, after giving effect to the blocker, are less.
- The securities were acquired for investment purposes and not with the intent to change or influence control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a neutral disclosure of a passive investment stake, typical for a Schedule 13G. It indicates institutional interest but provides no performance or strategic insights.
Positives
- Institutional investment by Altium Capital Management LLC and its affiliates in Femto Technologies Inc. indicates a level of investor interest.
Negatives
- The 'Warrant Blocker' limits Altium's ability to convert Series A Warrants if it would result in beneficial ownership exceeding 4.99% of outstanding common stock, restricting potential upside from full conversion.
Risks
- The 'Warrant Blocker' prevents the full exercise of Series A Warrants if it would lead to beneficial ownership exceeding 4.99% of Femto Technologies Inc.'s outstanding common stock, which could limit the investor's flexibility.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding institutional ownership, potentially signaling confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date for outstanding common stock count (2,926,526 shares) used for percentage calculation, based on Issuer's Form 20-F Amendment No. 1. |
| 05/02/2025 | Date Issuer's Amendment No. 1 to Form 20-F was filed with the SEC, providing the outstanding common stock count. |
| 06/30/2025 | Date of event which requires filing of this statement. |
| 08/14/2025 | Date of filing/signature by Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC. |
Recommendation
holdThe Schedule 13G filing discloses a small, passive ownership stake by Altium Capital Management and its affiliates in Femto Technologies Inc. This type of filing is a routine disclosure and does not provide sufficient new information regarding the company's financial performance, strategic direction, or operational outlook to warrant a change in investment recommendation. The disclosed stake is below the threshold for influencing control, and the presence of a 'Warrant Blocker' further limits the investor's potential influence. Therefore, a 'hold' recommendation is appropriate as the filing does not present new material information to alter an existing investment thesis.
Keywords
Femto Technologies Inc, Altium Capital Management, Schedule 13G, Common Stock, Beneficial Ownership, Warrants, Institutional Investment, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.